What is the price target for ALPHI stock?
8 analysts have analysed ALPHI.PA and the average price target is 3.4 EUR. This implies a price increase of 54.65% is expected in the next year compared to the current price of 2.2.
FACEPHI BIOMETRIA SA (ALPHI.PA) Forecast, Price Target & Analyst Ratings
EPA:ALPHI • ES0105029005
Current stock price
2.2 EUR
+0.06 (+2.8%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FACEPHI BIOMETRIA SA (ALPHI.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€3.40
Upside
+ 54.65%
From current price of €2.20 to mean target of €3.40, Based on 8 analyst forecasts
Low
€3.02
Median
€3.40
High
€3.87
Price Target Revisions
1 Month
0.00%
3 Months
-4.41%
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for ALPHI.PA. The average price target is 3.4 EUR. This implies a price increase of 54.65% is expected in the next year compared to the current price of 2.2.
The average price target has been revised downward by 4.41% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
ALPHI.PA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ALPHI.PA.
In the previous month the buy percentage consensus was at a similar level.
ALPHI.PA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2028
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 22.283M 69.30% | 25M 12.19% | 29M 16.00% | 37.366M 28.85% | 46.036M 23.20% | 53.516M 16.25% | 60.27M 12.62% | |
| EBITDA YoY % growth | 3.722M 445.19% | -600K -116.12% | -1.08M -80.00% | 6.885M 737.50% | 11.169M 62.22% | 15.606M 39.73% | 16.344M 4.73% | |
| EBIT YoY % growth | 1.748M 390.48% | -5.38M -407.71% | -6.67M -23.98% | 237.997K 103.57% | 2.686M 1,028.59% | 5.542M 106.33% | 10.215M 84.32% | |
| Operating Margin | 7.85% | -21.52% | -23.00% | 0.64% | 5.83% | 10.36% | 16.95% | |
| EPS YoY % growth | N/A | N/A -385.71% | N/A -66.67% | -0.02 94.00% | 0.05 350.00% | 0.19 273.34% | 0.27 39.50% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
36.80%
EPS Next 5 Year
29.14%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
21.66%
Revenue Next 5 Year
19.34%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
61.98%
EBIT Next 5 Year
44.47%
FACEPHI BIOMETRIA SA / ALPHI.PA Forecast FAQ
What is the next earnings date for ALPHI stock?
FACEPHI BIOMETRIA SA (ALPHI.PA) will report earnings on 2026-04-27.
What is the expected long term growth rate for ALPHI stock?
The expected long term growth rate for FACEPHI BIOMETRIA SA (ALPHI.PA) is 21.66%.